Tanzania: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Tanzania

The Tanzanian prophylactic medicaments containing insulin market declined slightly to $X in 2022, approximately mirroring the previous year. The market value increased at an average annual rate of +2.4% over the period from 2012 to 2022; however, the trend pattern remained relatively stable, with somewhat noticeable fluctuations being observed throughout the analyzed period. Over the period under review, the market reached the peak level at $X in 2018; however, from 2019 to 2022, consumption failed to regain momentum.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Tanzania

In value terms, prophylactic medicaments containing insulin production contracted slightly to $X in 2022 estimated in export price. The total output value increased at an average annual rate of +1.0% over the period from 2012 to 2022; however, the trend pattern remained consistent, with somewhat noticeable fluctuations being recorded in certain years. The pace of growth was the most pronounced in 2013 with an increase of 12%. Over the period under review, production hit record highs at $X in 2014; however, from 2015 to 2022, production stood at a somewhat lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Tanzania

In 2021, the amount of medicaments containing insulin but not antibiotics in measured doses exported from Tanzania stood at X tons, flattening at 2020. Over the period under review, exports posted significant growth. The smallest decline of 99.9% was in 2016. The exports peaked in 2021 and are likely to continue growth in years to come.

In value terms, prophylactic medicaments containing insulin exports stood at $X in 2021. Overall, exports showed a perceptible decrease. The smallest decline of 99.9% was in 2016. Over the period under review, the exports attained the maximum at $X in 2015; however, from 2016 to 2021, the exports stood at a somewhat lower figure.

Exports by Country

Swaziland (X tons) was the main destination for prophylactic medicaments containing insulin exports from Tanzania, accounting for a approx. 99% share of total exports.

From 2015 to 2021, the average annual growth rate of volume to Swaziland was relatively modest.

From 2015 to 2021, the average annual rate of growth in terms of value to Swaziland was relatively modest.

Export Prices by Country

The average prophylactic medicaments containing insulin export price stood at $X per ton in 2021, almost unchanged from the previous year. In general, the export price continues to indicate a dramatic decline. The pace of growth appeared the most rapid in 2016 a decrease of 99.9% against the previous year. Over the period under review, the average export prices hit record highs at $X per ton in 2015; however, from 2016 to 2021, the export prices failed to regain momentum.

As there is only one major export destination, the average price level is determined by prices for Swaziland.

From 2015 to 2021, the rate of growth in terms of prices for Uganda amounted to 0.0% per year.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Tanzania

Prophylactic medicaments containing insulin imports into Tanzania reduced to X tons in 2022, with a decrease of -12% on the year before. In general, imports, however, recorded a resilient increase. The most prominent rate of growth was recorded in 2013 with an increase of 159% against the previous year. Over the period under review, imports reached the peak figure at X tons in 2017; however, from 2018 to 2022, imports stood at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin imports shrank markedly to $X in 2022. Over the period under review, imports, however, posted a strong increase. The most prominent rate of growth was recorded in 2013 when imports increased by 150%. Imports peaked at $X in 2017; however, from 2018 to 2022, imports failed to regain momentum.

Imports by Country

India (X tons), France (X tons) and the UK (X kg) were the main suppliers of prophylactic medicaments containing insulin imports to Tanzania, together accounting for 96% of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by France (with a CAGR of +49.5%), while imports for the other leaders experienced more modest paces of growth.

In value terms, India ($X), Italy ($X) and France ($X) were the largest prophylactic medicaments containing insulin suppliers to Tanzania, together comprising 99% of total imports.

Italy, with a CAGR of +57.5%, recorded the highest growth rate of the value of imports, among the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2022, reducing by -19% against the previous year. In general, the import price continues to indicate a abrupt shrinkage. The pace of growth was the most pronounced in 2014 an increase of 25% against the previous year. As a result, import price attained the peak level of $X per ton. From 2015 to 2022, the average import prices remained at a somewhat lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Italy ($X per ton), while the price for France ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Kenya (+32.9%), while the prices for the other major suppliers experienced mixed trend patterns.

Source: IndexBox Platform